SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 1st, 2024 • Lipella Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 31, 2024, between Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT lipella pharmaceuticals inc.Security Agreement • August 1st, 2024 • Lipella Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledAugust 1st, 2024 Company IndustryTHIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 31, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of July 31, 2024, as amended, by and between the Company and H.C. Wainwright & Co., LLC.
PREFUNDED COMMON STOCK PURCHASE WARRANT lipella pharmaceuticals inc.Common Stock Purchase Warrant • August 1st, 2024 • Lipella Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledAugust 1st, 2024 Company IndustryTHIS PREFUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIAL Lipella Pharmaceuticals Inc.Underwriting Agreement • August 1st, 2024 • Lipella Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2024 Company Industry Jurisdiction